<--- Back to Details
First PageDocument Content
Clinical medicine / Medicine / Cancer / RTT / Cancer treatments / Antineoplastic drugs / Oncology / Chemotherapy regimens / Chemotherapy / Docetaxel / Adjuvant therapy / Breast cancer
Date: 2015-10-23 13:19:22
Clinical medicine
Medicine
Cancer
RTT
Cancer treatments
Antineoplastic drugs
Oncology
Chemotherapy regimens
Chemotherapy
Docetaxel
Adjuvant therapy
Breast cancer

Original Research Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy Elyce Cardonick,

Add to Reading List

Source URL: 192.138.189.65

Download Document from Source Website

File Size: 171,81 KB

Share Document on Facebook

Similar Documents

Original Research  Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy Elyce Cardonick,

Original Research Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy Elyce Cardonick,

DocID: 1rr4j - View Document

TPS5609  A phase 2, open-label study of niraparib in women with advanced, relapsed, high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer after ≥3 previous chemotherapy regimens Kathleen N.

TPS5609 A phase 2, open-label study of niraparib in women with advanced, relapsed, high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer after ≥3 previous chemotherapy regimens Kathleen N.

DocID: 1lAWB - View Document

fluorouracil pain relief, fluorouracil opthalmic solution fluorouracil generic alternative, fluorouracil package insert ic fluorouracil, wikipedia fluorouracil genital warts and fluorouracil. fluorouracil msds, fluoroura

fluorouracil pain relief, fluorouracil opthalmic solution fluorouracil generic alternative, fluorouracil package insert ic fluorouracil, wikipedia fluorouracil genital warts and fluorouracil. fluorouracil msds, fluoroura

DocID: 1fzbO - View Document

continuing education Disclosure of Conflicts of Interest The Nurse Practitioner Healthcare Foundation (NPHF) assesses conflict of interest with its instructors, planners, reviewers, and other individuals who are in a pos

continuing education Disclosure of Conflicts of Interest The Nurse Practitioner Healthcare Foundation (NPHF) assesses conflict of interest with its instructors, planners, reviewers, and other individuals who are in a pos

DocID: 19tAL - View Document

Kaposi Sarcoma Protocol Pre-Treatment Documentation Date of HIV Diagnosis: Date of KS Diagnosis:

Kaposi Sarcoma Protocol Pre-Treatment Documentation Date of HIV Diagnosis: Date of KS Diagnosis:

DocID: 18Qlw - View Document